| mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
Roscovitine |
GDSC1000 |
pan-cancer |
AAC |
-0.0077 |
0.9 |
| mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.9 |